A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

BACKGROUND: The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells in vivo. Accordingly, immunological assays that demonstrate recognition of native tumor cells (tumor-specific) may be more clinically rele...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Transl Med
Autors principals:	Malyguine, Anatoli, Strobl, Susan L, Shafer-Weaver, Kimberly A, Ulderich, Tracy, Troke, Angela, Baseler, Michael, Kwak, Larry W, Neelapu, Sattva S
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2004
Matèries:	Methodology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415560/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15050026/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1479-5876-2-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!